Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy
Abstract The impact of tumor infiltrating lymphocytes (TILs) on survival was confirmed in various cancer types. Our study aims to investigate the prognostic role of TILs on survival in patients with metastatic urothelial carcinoma (mUC) receiving platinum based chemotherapy. Patients who were diagno...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0115a41fc34e4ccb9ec9539b02e5dec2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0115a41fc34e4ccb9ec9539b02e5dec2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0115a41fc34e4ccb9ec9539b02e5dec22021-12-02T11:41:24ZPrognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy10.1038/s41598-018-25944-12045-2322https://doaj.org/article/0115a41fc34e4ccb9ec9539b02e5dec22018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25944-1https://doaj.org/toc/2045-2322Abstract The impact of tumor infiltrating lymphocytes (TILs) on survival was confirmed in various cancer types. Our study aims to investigate the prognostic role of TILs on survival in patients with metastatic urothelial carcinoma (mUC) receiving platinum based chemotherapy. Patients who were diagnosed to have pathologically proved mUC between 1997 and 2016 and received palliative chemotherapy with platinum based regimen were recruited into our study. Kaplan-Meier curves and Cox regression analysis were constructed for overall survival (OS). A total of 259 mUC patients were enrolled into our study with median age 63 years and median follow-up visit 13.5 months. Of these patients, 179 (69%) had intense TILs and 80 (31%) had non-intense TILs. The median OS were 15.7 vs. 6.7 months (P = < 0.001) for patients with intense TILs and non-intense TILs, respectively. Subgroup analysis showed that TILs was both prognostically significant no matter for urothelial carcinoma of bladder and upper tract urothelial carcinoma. Multivariate analysis showed that TILs were strongly prognostic factors related to OS. Our study suggested mUC patients with intense TILs were independently associated with survival. Based on our study, TILs is clinically useful for outcomes anticipation and risk stratification, as well as patients counseling.Hui-Shan HuangHarvey Yu-Li SuPei-Hsu LiPo-Hui ChiangCheng-Hua HuangChien-Hsu ChenMeng-Che HsiehNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-7 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Hui-Shan Huang Harvey Yu-Li Su Pei-Hsu Li Po-Hui Chiang Cheng-Hua Huang Chien-Hsu Chen Meng-Che Hsieh Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy |
description |
Abstract The impact of tumor infiltrating lymphocytes (TILs) on survival was confirmed in various cancer types. Our study aims to investigate the prognostic role of TILs on survival in patients with metastatic urothelial carcinoma (mUC) receiving platinum based chemotherapy. Patients who were diagnosed to have pathologically proved mUC between 1997 and 2016 and received palliative chemotherapy with platinum based regimen were recruited into our study. Kaplan-Meier curves and Cox regression analysis were constructed for overall survival (OS). A total of 259 mUC patients were enrolled into our study with median age 63 years and median follow-up visit 13.5 months. Of these patients, 179 (69%) had intense TILs and 80 (31%) had non-intense TILs. The median OS were 15.7 vs. 6.7 months (P = < 0.001) for patients with intense TILs and non-intense TILs, respectively. Subgroup analysis showed that TILs was both prognostically significant no matter for urothelial carcinoma of bladder and upper tract urothelial carcinoma. Multivariate analysis showed that TILs were strongly prognostic factors related to OS. Our study suggested mUC patients with intense TILs were independently associated with survival. Based on our study, TILs is clinically useful for outcomes anticipation and risk stratification, as well as patients counseling. |
format |
article |
author |
Hui-Shan Huang Harvey Yu-Li Su Pei-Hsu Li Po-Hui Chiang Cheng-Hua Huang Chien-Hsu Chen Meng-Che Hsieh |
author_facet |
Hui-Shan Huang Harvey Yu-Li Su Pei-Hsu Li Po-Hui Chiang Cheng-Hua Huang Chien-Hsu Chen Meng-Che Hsieh |
author_sort |
Hui-Shan Huang |
title |
Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy |
title_short |
Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy |
title_full |
Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy |
title_fullStr |
Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy |
title_full_unstemmed |
Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy |
title_sort |
prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/0115a41fc34e4ccb9ec9539b02e5dec2 |
work_keys_str_mv |
AT huishanhuang prognosticimpactoftumorinfiltratinglymphocytesonpatientswithmetastaticurothelialcarcinomareceivingplatinumbasedchemotherapy AT harveyyulisu prognosticimpactoftumorinfiltratinglymphocytesonpatientswithmetastaticurothelialcarcinomareceivingplatinumbasedchemotherapy AT peihsuli prognosticimpactoftumorinfiltratinglymphocytesonpatientswithmetastaticurothelialcarcinomareceivingplatinumbasedchemotherapy AT pohuichiang prognosticimpactoftumorinfiltratinglymphocytesonpatientswithmetastaticurothelialcarcinomareceivingplatinumbasedchemotherapy AT chenghuahuang prognosticimpactoftumorinfiltratinglymphocytesonpatientswithmetastaticurothelialcarcinomareceivingplatinumbasedchemotherapy AT chienhsuchen prognosticimpactoftumorinfiltratinglymphocytesonpatientswithmetastaticurothelialcarcinomareceivingplatinumbasedchemotherapy AT mengchehsieh prognosticimpactoftumorinfiltratinglymphocytesonpatientswithmetastaticurothelialcarcinomareceivingplatinumbasedchemotherapy |
_version_ |
1718395380912095232 |